Cat.#: ACPP-1223
| Despition | PAX8 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1492 | Human PGLYRP1 Protein (AC1492) | 2 µg | inquiry |
| ACPP-1120 | Human NRG1 Protein (AC1120) | 10 µg | inquiry |
| ACPP-1670 | Mouse BDNF Protein (AC1670) | 2 µg | inquiry |
| ACPP-1499 | Mouse RAPSN Protein (AC1499) | 5 µg | inquiry |
| ACPP-1825 | Human ANKRA2 Protein (AC1825) | 2 µg | inquiry |
| ACPP-1688 | Human CDK1 Protein, Sf9 (AC1688) | 2 µg | inquiry |
| ACPP-1438 | Human NDRG2 Protein (AC1438) | 5 µg | inquiry |
| ACPP-1337 | Neurochondrin Blocking Peptide (AC1337) | 250 µg | inquiry |
| ACPP-1783 | Human SAT2 Protein (AC1783) | 5 µg | inquiry |
| ACPP-1313 | Norepinephrine Transporter Blocking Peptide (AC1313) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.